1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of MSX2 mRNA CTD PMID:21058326 17alpha-ethynylestradiol increases expression ISO RGD:10921 6480464 Ethinyl Estradiol results in increased expression of MSX2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:10921 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSX2 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:735997 6480464 Estradiol results in decreased expression of MSX2 mRNA CTD PMID:19167446 17beta-estradiol multiple interactions ISO RGD:10921 6480464 [Polyphenols co-treated with Estradiol] results in decreased expression of MSX2 mRNA CTD PMID:30077407 17beta-estradiol increases expression ISO RGD:10921 6480464 Estradiol results in increased expression of MSX2 mRNA CTD PMID:17450229 , PMID:30077407 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10921 6480464 Tetrachlorodibenzodioxin affects the expression of MSX2 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10921 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSX2 mRNA CTD PMID:17942748 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of MSX2 mRNA CTD PMID:21346803 2-ethylhexan-1-ol increases expression ISO RGD:10921 6480464 2-ethylhexanol results in increased expression of MSX2 mRNA CTD PMID:31445079 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of MSX2 mRNA CTD PMID:23358152 4,4'-sulfonyldiphenol increases expression ISO RGD:10921 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MSX2 mRNA CTD PMID:30951980 5-fluorouracil affects response to substance ISO RGD:735997 6480464 MSX2 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-fluorouracil decreases expression ISO RGD:735997 6480464 Fluorouracil results in decreased expression of MSX2 protein CTD PMID:15352031 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of MSX2 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:735997 6480464 Aflatoxin B1 results in decreased methylation of MSX2 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:10921 6480464 Tretinoin results in increased expression of MSX2 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO RGD:735997 6480464 Tretinoin results in decreased expression of MSX2 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:735997 6480464 Tretinoin results in increased expression of MSX2 mRNA CTD PMID:17138961 , PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MSX2 mRNA CTD PMID:16483693 arsenite(3-) increases methylation ISO RGD:735997 6480464 arsenite results in increased methylation of MSX2 promoter CTD PMID:23974009 arsenous acid decreases response to substance ISO RGD:735997 6480464 MSX2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 belinostat multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA CTD PMID:27188386 belinostat increases expression ISO RGD:735997 6480464 belinostat results in increased expression of MSX2 mRNA CTD PMID:26272509 benzalkonium chloride multiple interactions ISO RGD:10921 6480464 [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MSX2 mRNA CTD PMID:30171875 benzo[a]pyrene decreases expression ISO RGD:10921 6480464 Benzo(a)pyrene results in decreased expression of MSX2 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:735997 6480464 Benzo(a)pyrene results in increased expression of MSX2 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:735997 6480464 Benzo(a)pyrene affects the methylation of MSX2 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:735997 6480464 Benzo(a)pyrene results in increased methylation of MSX2 exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10921 6480464 Benzo(a)pyrene results in increased expression of MSX2 mRNA CTD PMID:23735875 benzo[e]pyrene decreases methylation ISO RGD:735997 6480464 benzo(e)pyrene results in decreased methylation of MSX2 intron CTD PMID:30157460 bisphenol A decreases expression ISO RGD:735997 6480464 bisphenol A results in decreased expression of MSX2 mRNA CTD PMID:22576693 bisphenol A increases expression ISO RGD:10921 6480464 bisphenol A results in increased expression of MSX2 mRNA CTD PMID:30951980 bisphenol A affects methylation ISO RGD:10921 6480464 bisphenol A affects the methylation of MSX2 promoter CTD PMID:27334623 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MSX2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MSX2 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A decreases expression ISO RGD:10921 6480464 bisphenol A results in decreased expression of MSX2 mRNA CTD PMID:26063408 bisphenol A increases methylation ISO RGD:735997 6480464 bisphenol A results in increased methylation of MSX2 gene CTD PMID:22576693 bisphenol F increases expression ISO RGD:10921 6480464 bisphenol F results in increased expression of MSX2 mRNA CTD PMID:30951980 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of MSX2 promoter CTD PMID:22457795 cadmium sulfate multiple interactions ISO RGD:10921 6480464 cadmium sulfate inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of MSX2 mRNA] CTD PMID:28189605 calcitriol increases expression ISO RGD:735997 6480464 Calcitriol results in increased expression of MSX2 mRNA CTD PMID:16002434 carbamazepine affects expression ISO RGD:735997 6480464 Carbamazepine affects the expression of MSX2 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:10921 6480464 Nanotubes, Carbon analog affects the expression of MSX2 mRNA CTD PMID:21624382 CGP 52608 multiple interactions ISO RGD:735997 6480464 CGP 52608 promotes the reaction [RORA protein binds to MSX2 gene] CTD PMID:28238834 cobalt dichloride increases expression ISO RGD:735997 6480464 cobaltous chloride results in increased expression of MSX2 mRNA CTD PMID:19376846 copper atom increases expression EXP 6480464 Copper results in increased expression of MSX2 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of MSX2 mRNA CTD PMID:30556269 coumestrol decreases expression ISO RGD:735997 6480464 Coumestrol results in decreased expression of MSX2 mRNA CTD PMID:19167446 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MSX2 mRNA CTD PMID:26577399 deoxynivalenol increases expression ISO RGD:735997 6480464 deoxynivalenol results in increased expression of MSX2 mRNA CTD PMID:31863870 dexamethasone multiple interactions ISO RGD:10921 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of MSX2 mRNA, cadmium sulfate inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of MSX2 mRNA] CTD PMID:28189605 diarsenic trioxide decreases response to substance ISO RGD:735997 6480464 MSX2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diethylstilbestrol decreases expression ISO RGD:10921 6480464 Diethylstilbestrol results in decreased expression of MSX2 mRNA CTD PMID:16513791 diethylstilbestrol increases expression ISO RGD:10921 6480464 Diethylstilbestrol results in increased expression of MSX2 mRNA CTD PMID:17394237 diethylstilbestrol affects response to substance ISO RGD:10921 6480464 MSX2 affects the susceptibility to Diethylstilbestrol CTD PMID:15591538 diethylstilbestrol decreases response to substance ISO RGD:10921 6480464 MSX2 protein results in decreased susceptibility to Diethylstilbestrol CTD PMID:16513791 dioxygen decreases expression ISO RGD:735997 6480464 Oxygen deficiency results in decreased expression of MSX2 mRNA CTD PMID:24236059 dorsomorphin multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:735997 6480464 Doxorubicin results in decreased expression of MSX2 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:735997 6480464 entinostat results in increased expression of MSX2 mRNA CTD PMID:26272509 folic acid decreases expression ISO RGD:10921 6480464 Folic Acid results in decreased expression of MSX2 mRNA CTD PMID:25629700 furan decreases expression EXP 6480464 furan results in decreased expression of MSX2 mRNA CTD PMID:25539665 genistein decreases expression ISO RGD:10921 6480464 Genistein results in decreased expression of MSX2 mRNA CTD PMID:32186404 glycerol 2-phosphate multiple interactions ISO RGD:10921 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of MSX2 mRNA, cadmium sulfate inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of MSX2 mRNA] CTD PMID:28189605 hexaconazole decreases expression ISO RGD:10921 6480464 hexaconazole results in decreased expression of MSX2 mRNA CTD PMID:22045034 L-ascorbic acid multiple interactions ISO RGD:10921 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of MSX2 mRNA, cadmium sulfate inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of MSX2 mRNA] CTD PMID:28189605 lead diacetate decreases expression ISO RGD:10921 6480464 lead acetate results in decreased expression of MSX2 mRNA CTD PMID:22609695 lipopolysaccharide decreases expression ISO RGD:10921 6480464 Lipopolysaccharides results in decreased expression of MSX2 mRNA CTD PMID:12057914 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of MSX2 mRNA CTD PMID:28801915 mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of MSX2 mRNA CTD PMID:23358152 mercury dibromide increases expression ISO RGD:735997 6480464 mercuric bromide results in increased expression of MSX2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA CTD PMID:27188386 methapyrilene decreases methylation ISO RGD:735997 6480464 Methapyrilene results in decreased methylation of MSX2 intron CTD PMID:30157460 methylmercury chloride increases expression ISO RGD:735997 6480464 methylmercuric chloride results in increased expression of MSX2 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA CTD PMID:27188386 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of MSX2 mRNA CTD PMID:21515302 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MSX2 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of MSX2 mRNA CTD PMID:20360939 p-chloromercuribenzoic acid increases expression ISO RGD:735997 6480464 p-Chloromercuribenzoic Acid results in increased expression of MSX2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:735997 6480464 panobinostat results in increased expression of MSX2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA CTD PMID:27188386 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of MSX2 mRNA CTD PMID:20360939 phenylmercury acetate increases expression ISO RGD:735997 6480464 Phenylmercuric Acetate results in increased expression of MSX2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA CTD PMID:27188386 progesterone multiple interactions ISO RGD:10921 6480464 [Estrogens co-treated with Progesterone] results in increased expression of MSX2 mRNA CTD PMID:17546050 progesterone decreases expression ISO RGD:10921 6480464 Progesterone results in decreased expression of MSX2 mRNA CTD PMID:22238285 progesterone increases expression ISO RGD:10921 6480464 Progesterone results in increased expression of MSX2 mRNA CTD PMID:17546050 purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of MSX2 mRNA CTD PMID:23358152 retinyl acetate increases expression ISO RGD:10921 6480464 retinol acetate results in increased expression of MSX2 mRNA CTD PMID:16772331 SB 431542 multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:735997 6480464 Silicon Dioxide analog results in increased expression of MSX2 mRNA CTD PMID:23806026 sunitinib decreases expression ISO RGD:735997 6480464 Sunitinib results in decreased expression of MSX2 mRNA CTD PMID:31533062 tebuconazole decreases expression ISO RGD:735997 6480464 tebuconazole results in decreased expression of MSX2 mRNA CTD PMID:30458266 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of MSX2 mRNA CTD PMID:21515302 triadimefon decreases expression EXP 6480464 triadimefon results in decreased expression of MSX2 mRNA CTD PMID:21254369 trichostatin A increases expression ISO RGD:735997 6480464 trichostatin A results in increased expression of MSX2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA CTD PMID:27188386 tripotassium phosphate increases expression EXP 6480464 potassium phosphate results in increased expression of MSX2 mRNA CTD PMID:24561004 tripotassium phosphate multiple interactions EXP 6480464 Fluorides inhibits the reaction [potassium phosphate results in increased expression of MSX2 mRNA] CTD PMID:24561004 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of MSX2 mRNA CTD PMID:21515302 valproic acid decreases methylation ISO RGD:735997 6480464 Valproic Acid results in decreased methylation of MSX2 gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of MSX2 mRNA CTD PMID:35594946 valproic acid affects expression ISO RGD:10921 6480464 Valproic Acid affects the expression of MSX2 mRNA CTD PMID:34537371 valproic acid increases expression ISO RGD:10921 6480464 Valproic Acid results in increased expression of MSX2 mRNA CTD PMID:19136453 , PMID:31445079 valproic acid decreases expression ISO RGD:10921 6480464 Valproic Acid analog results in decreased expression of MSX2 mRNA, Valproic Acid results in decreased expression of MSX2 mRNA CTD PMID:22045034 , PMID:30578912 valproic acid affects expression ISO RGD:735997 6480464 Valproic Acid affects the expression of MSX2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:735997 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:735997 6480464 Valproic Acid results in increased expression of MSX2 mRNA CTD PMID:19101580 more ...